Prediction of Metabolic Transformations using Cross Venn-ABERS Predictors

Prediction of drug metabolism is an important topic in the drug discovery process, and we here present a study using probabilistic predictions applying Cross Venn-ABERS Predictors (CVAPs) on data f ...

[1]  Peter Gedeck,et al.  Exploiting QSAR models in lead optimization. , 2008, Current opinion in drug discovery & development.

[2]  Scott Boyer,et al.  Introducing Conformal Prediction in Predictive Modeling. A Transparent and Flexible Alternative to Applicability Domain Determination , 2014, J. Chem. Inf. Model..

[3]  V. Vovk,et al.  Large-scale probabilistic predictors with and without guarantees of validity , 2015, 1511.00213.

[4]  C. Hansch.  Quantitative approach to biochemical structure-activity relationships , 1969 .

[5]  David E. Gloriam,et al.  SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. , 2010, ACS medicinal chemistry letters.

[6]  Egon L. Willighagen,et al.  The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..

[7]  Jean-Loup Faulon,et al.  The Signature Molecular Descriptor. 1. Using Extended Valence Sequences in QSAR and QSPR Studies , 2003, J. Chem. Inf. Comput. Sci..

[8]  W. Gasarch,et al.  The Book Review Column 1 Coverage Untyped Systems Simple Types Recursive Types Higher-order Systems General Impression 3 Organization, and Contents of the Book , 2022 .

[9]  Beate I Escher,et al.  Toward a class-independent quantitative structure--activity relationship model for uncouplers of oxidative phosphorylation. , 2008, Chemical research in toxicology.

[10]  Stephen R. Johnson,et al.  A computational model for the prediction of aqueous solubility that includes crystal packing, intrinsic solubility, and ionization effects. , 2007, Molecular pharmaceutics.

[11]  Christoph Helma,et al.  Lazy structure-activity relationships (lazar) for the prediction of rodent carcinogenicity and Salmonella mutagenicity , 2006, Molecular Diversity.

[12]  C. Steinbeck,et al.  Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.

[13]  Enrique Fernández-Blanco,et al.  Drug discovery and design for complex diseases through QSAR computational methods. , 2010, Current pharmaceutical design.

[14]  Robert P. Sheridan,et al.  Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..

[15]  Ola Spjuth,et al.  Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse , 2010, BMC Bioinformatics.

[16]  Bernard F. Buxton,et al.  Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..

[17]  Ola Spjuth,et al.  Benchmarking Study of Parameter Variation When Using Signature Fingerprints Together with Support Vector Machines , 2014, J. Chem. Inf. Model..

[18]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..